Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection von Jacobson, Ira M, McHutchison, John G, Dusheiko, Geoffrey, Di Bisceglie, Adrian M, Reddy, K. Rajender, Bzowej, Natalie H, Marcellin, Patrick, Muir, Andrew J, Ferenci, Peter, Flisiak, Robert, George, Jacob, George, Shelley, Rizzetto, Mario, Shouval, Daniel, Sola, Ricard, Terg, Ruben A, Yoshida, Eric M, Adda, Nathalie, Bengtsson, Leif, Sankoh, Abdul J, Kieffer, Tara L, Kauffman, Robert S, M.D, Stefan Zeuzem

Volltext

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection von Sherman, Kenneth E, Flamm, Steven L, Afdhal, Nezam H, Nelson, David R, Sulkowski, Mark S, Everson, Gregory T, Fried, Michael W, Adler, Michael, Reesink, Hendrik W, Martin, Marie, Sankoh, Abdul J, Adda, Nathalie, Kauffman, Robert S, George, Shelley, Wright, Christopher I, Poordad, Fred

Volltext

Complications of fluid overload during hysteroscopic surgery von Hoffman, Christopher Ryan, Van Hal, Michele, Tariq, Rayhan, George, Shelley

Volltext

Patient perception of pain care in the United States: a 5-year comparative analysis of hospital consumer assessment of health care providers and systems von Gupta, Anita, Lee, Lisa K, Mojica, Jeffrey J, Nairizi, Ali, George, Shelley J

Volltext

Academic faculty demonstrate higher well-being than residents: Pennsylvania anesthesiology programs' results of the 2017–2018 ACGME well-being survey von Adams, Phillip S., Gordon, Emily K.B., Berkeley, Abiona, Monroe, Brian, Eckert, Jill M., Maldonado, Yasdet, Heitz, James W., George, Shelley, Metro, David G.

Volltext

Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro von Nielsen, Vance G, George, Shelley J

Volltext

Characterization of V36C, a Novel Amino Acid Substitution Conferring Hepatitis C Virus (HCV) Resistance to Telaprevir, a Potent Peptidomimetic Inhibitor of HCV Protease von Barbotte, Laetitia, Ahmed-Belkacem, Abdelhakim, Chevaliez, Stéphane, Soulier, Alexandre, Hézode, Christophe, Wajcman, Henri, Bartels, Doug J, Zhou, Yi, Ardzinski, Andrzej, Mani, Nagraj, Rao, B Govinda, George, Shelley, Kwong, Ann, Pawlotsky, Jean-Michel

Volltext

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection von Hézode, Christophe, Forestier, Nicole, Dusheiko, Geoffrey, Ferenci, Peter, Pol, Stanislas, Goeser, Tobias, Bronowicki, Jean-Pierre, Bourlière, Marc, Gharakhanian, Shahin, Bengtsson, Leif, McNair, Lindsay, George, Shelley, Kieffer, Tara, Kwong, Ann, Kauffman, Robert S, Alam, John, Pawlotsky, Jean-Michel, Zeuzem, Stefan

Volltext

Telaprevir for Previously Treated Chronic HCV Infection von McHutchison, John G, Manns, Michael P, Muir, Andrew J, Terrault, Norah A, Jacobson, Ira M, Afdhal, Nezam H, Heathcote, E. Jenny, Zeuzem, Stefan, Reesink, Hendrik W, Garg, Jyotsna, Bsharat, Mohammad, George, Shelley, Kauffman, Robert S, Adda, Nathalie, M.D, Adrian M. Di Bisceglie

Volltext

Resistance to hepatitis C virus protease inhibitors von Kieffer, Tara L, George, Shelley

Volltext

Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitors von Kwong, Ann D, McNair, Lindsay, Jacobson, Ira, George, Shelley

Volltext

Hepatitis C pharmacogenetics: State of the art in 2010 von Afdhal, Nezam H., McHutchison, John G., Zeuzem, Stefan, Mangia, Alessandra, Pawlotsky, Jean‐Michel, Murray, Jeffrey S., Shianna, Kevin V., Tanaka, Yasuhito, Thomas, David L., Booth, David R., Goldstein, David B.

Volltext

Retreatment with telaprevir combination therapy in hepatitis C patients with well‐characterized prior treatment response von Muir, Andrew J., Poordad, Fred F., McHutchison, John G., Shiffman, Mitchell L., Berg, Thomas, Ferenci, Peter, Heathcote, E. Jenny, Pawlotsky, Jean‐Michel, Zeuzem, Stefan, Reesink, Henk W., Dusheiko, Geoffrey, Martin, Emily C., George, Shelley, Kauffman, Robert S., Adda, Nathalie

Volltext

Reply von McHutchison, John G., George, Shelley, Kauffman, Robert S.

Volltext

Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure von Foster, Graham R, Zeuzem, Stefan, Andreone, Pietro, Pol, Stanislas, Lawitz, Eric J, Diago, Moises, Roberts, Stuart, Pockros, Paul J, Younossi, Zobair, Lonjon-Domanec, Isabelle, De Meyer, Sandra, Luo, Don, George, Shelley, Beumont, Maria, Picchio, Gaston

Volltext

Christian civilizations / by George Shelley Hughes von Hughes, George Shelley

Volltext bestellen

Ancient civilizations. By George Shelley Hughs von Hughs, George Shelley, 1849

Volltext bestellen

Corporations and trade unions ... / by George Shelley Hughs von Hughs, George Shelley

Volltext bestellen

VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection von Di Bisceglie, Adrian M, Sulkowski, Mark, Gane, Ed, Jacobson, Ira M, Nelson, David, DeSouza, Cynthia, Alves, Katia, George, Shelley, Kieffer, Tara, Zhang, Eileen Z, Kauffman, Robert, Asmal, Mohammed, Koziel, Margaret J

Volltext

Sustained Virologic Response Rates With Telaprevir-Based Therapy in Treatment-Naive Patients Evaluated by Race or Ethnicity von Flamm, Steven L, Muir, Andrew J, Fried, Michael W, Reddy, K Rajender, Nelson, David R, Bzowej, Natalie H, Sullivan, James C, Bengtsson, Leif, DeMasi, Ralph, Wright, Christopher I, Kieffer, Tara L, George, Shelley, Adda, Nathalie, Dusheiko, Geoffrey M

Volltext